Autologous Stem Cell Transplant Consolidation Is Associated With Improved Overall Survival in Angioimmunoblastic T‐Cell Lymphoma: A Real‐World National Cancer Database Study
Hematological Oncology · 2026
DOI: 10.1002/hon.70222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematological Oncology, 2026. Verfasst von Yu Tao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, China. Hauptthemen laut MEDLINE: Immunoblastic Lymphadenopathy, Hematopoietic Stem Cell Transplantation, Lymphoma, T-Cell, Peripheral, Lymphoma, T-Cell. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Shenzhen Science and Technology Program, National Natural Science Foundation of China, Shenzhen Outstanding Scientific and Technological Innovation Talent Training Program.
Abstract (Originalsprache)
Angioimmunoblastic T‐cell lymphoma (AITL) is an aggressive peripheral T‐cell lymphoma with poor outcomes, and the role of autologous stem cell transplantation (ASCT) as consolidation after frontline therapy remains controversial. We conducted a retrospective cohort study using the National Cancer Database, including adults diagnosed with AITL between 2004 and 2020 who received frontline systemic therapy. Patients were categorized as chemotherapy alone (Chemo) or chemotherapy followed by ASCT (Chemo + ASCT). To mitigate immortal time bias, prespecified landmark analyses were performed, with a 6‐month landmark analysis as the primary approach and a 9‐month landmark analysis as a sensitivity analysis. Multivariable Cox regression and propensity score weighting using inverse probability of treatment weighting for the average treatment effect were used to address measured confounding. Among 3996 patients receiving systemic therapy, 686 (17.2%) underwent ASCT. In the 6‐month landmark analysis, ASCT was associated with improved overall survival (HR, 0.53; 95% CI, 0.45–0.62; p < 0.001). Findings were consistent in the 9‐month landmark analysis (HR, 0.58; 95% CI, 0.49–0.69; p < 0.001) and IPTW‐adjusted model (HR, 0.51; 95% CI, 0.44–0.60; p < 0.001). In this large real‐world cohort, ASCT consolidation was consistently associated with improved survival in patients with AITL. Although treatment‐response data were unavailable and residual confounding cannot be excluded, these findings provide supportive real‐world evidence and warrant prospective studies with treatment‐timing and response data to better define patient selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, The First Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
- Department of Hematology, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China.
- Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Ayo S Falade, Steven R Hwang, Urshila Durani, Stephen M Ansell, Yucai Wang, Jihao Zhou
Förderung
- Shenzhen Science and Technology Program
- National Natural Science Foundation of China
- Shenzhen Outstanding Scientific and Technological Innovation Talent Training Program
Zitieren
APA
Tao, Y., Li, H., Falade, A. S., Godby, R. C., Hwang, S. R., Nowakowski, G. S., Durani, U., Tiger, Y. K., Bennani, N. N., Ansell, S. M., Wang, Y., & Zhou, J. (2026). Autologous Stem Cell Transplant Consolidation Is Associated With Improved Overall Survival in Angioimmunoblastic T‐Cell Lymphoma: A Real‐World National Cancer Database Study. Hematological Oncology. https://doi.org/10.1002/hon.70222
Vancouver
Tao Y, Li H, Falade AS, Godby RC, Hwang SR, Nowakowski GS, et al. Autologous Stem Cell Transplant Consolidation Is Associated With Improved Overall Survival in Angioimmunoblastic T‐Cell Lymphoma: A Real‐World National Cancer Database Study. Hematological Oncology. 2026. doi:10.1002/hon.70222
BibTeX
@article{Tao2026,
author = {Tao, Yu and Li, Huijun and Falade, Ayo S and Godby, Richard C and Hwang, Steven R and Nowakowski, Grzegorz S and Durani, Urshila and Tiger, Yun Kyoung and Bennani, N Nora and Ansell, Stephen M and Wang, Yucai and Zhou, Jihao},
title = {Autologous Stem Cell Transplant Consolidation Is Associated With Improved Overall Survival in Angioimmunoblastic T‐Cell Lymphoma: A Real‐World National Cancer Database Study},
journal = {Hematological Oncology},
year = {2026},
doi = {10.1002/hon.70222}
}
EUVIMED